Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ARMP
ARMP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ARMP News
ARMATA PHARMACEUTICALS INC REPORTS Q4 2025 NET LOSS OF $3.42 PER SHARE
5d ago
moomoo
Armata Pharmaceuticals Q4 Earnings Report Analysis
4d ago
seekingalpha
Armata Pharmaceuticals Delays 2025 Financial Reporting
Mar 19 2026
NASDAQ.COM
Armata Pharmaceuticals Delays Financial Results and Receives FDA Recognition
Mar 19 2026
Newsfilter
Significant Milestones in Biotech Sector This Week
Feb 27 2026
NASDAQ.COM
Armata Receives FDA QIDP Designation for Staphylococcus aureus Treatment
Feb 23 2026
Newsfilter
Armata Pharmaceuticals' AP-SA02 Advances to Phase 3 Clinical Study Following Positive FDA Feedback
Jan 13 2026
NASDAQ.COM
Armata Pharmaceuticals' AP-SA02 Advances to Phase 3 Clinical Trial Following FDA Approval
Jan 13 2026
PRnewswire
Armata Pharmaceuticals' AP-SA02 Advances to Phase 3 Clinical Study with FDA Support
Jan 13 2026
Newsfilter
Coherus Oncology (CHRS) Posts Q3 Loss and Falls Short of Revenue Projections
Nov 07 2025
NASDAQ.COM
Armata Pharmaceuticals (ARMP) Soars 103.2%: Could This Signal More Upside Ahead?
Oct 23 2025
NASDAQ.COM
Reasons Behind the 300% Surge in Armata Pharmaceuticals Stock (ARMP) Today
Oct 22 2025
TipRanks
Armata Rises Following Mid-Stage Trial Results for Antibacterial Drug
Oct 22 2025
SeekingAlpha
Armata Pharmaceuticals Reveals Publication on Structural Biology in the Journal of Molecular Biology
Sep 08 2025
Newsfilter
All You Need to Know About Armata Pharmaceuticals (ARMP) Rating Upgrade to Buy
Aug 15 2025
NASDAQ.COM
Armata Posts 59 Percent Q2 Revenue Jump
Aug 13 2025
NASDAQ.COM
Show More News
